antivirals

Pharma

Roche signs generic Xofluza licensing deal with MPP

Under the Roche deal, MPP is seeking applications from generic makers that have the capacity to support the development and supply of generic Xofluza.

Angus Liu May 19, 2026 11:15am

Fierce Biotech

HHS launches $100M prize to develop antiviral therapies

Feb 3, 2026 4:00pm

Capturing COVID: Biopharma through the lens during the pandemic

Nov 13, 2023 7:45am

Merck's Lagevrio may have triggered new COVID variants: study

Sep 26, 2023 9:35am

Carvykti, Sanofi, BeiGene—Fierce Pharma Asia

Feb 3, 2023 8:25am

Pfizer's Paxlovid access questioned ahead of WTO patent talks

Nov 21, 2022 11:41am